| Literature DB >> 12667469 |
S J Crocker1, P Liston, H Anisman, C J Lee, P D Smith, N Earl, C S Thompson, D S Park, R G Korneluk, G S Robertson.
Abstract
X-linked IAP protein is a potent inhibitor of cell death. Here, we describe a novel transgenic mouse in which the human XIAP gene is expressed under the control of the neuron-specific enolase promoter (NSE-xiap). We demonstrate that nigrostriatal dopamine neurons of NSE-xiap mice were resistant to the damaging effects of the dopaminergic neurotoxin MPTP. MPTP-induced reduction of striatal dopamine metabolism was also attenuated in NSE-xiap mice. Furthermore, NSE-xiap mice treated with MPTP did not exhibit deficits in exploratory behaviour in an open-field test. Taken together, these findings suggest that strategies to enhance neuronal expression of XIAP may provide therapeutic benefit for the treatment of neurodegeneration in Parkinson's disease. Copyright 2003 Elsevier Science (USA)Entities:
Mesh:
Substances:
Year: 2003 PMID: 12667469 DOI: 10.1016/s0969-9961(02)00020-7
Source DB: PubMed Journal: Neurobiol Dis ISSN: 0969-9961 Impact factor: 5.996